Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Bioretec

1,835

 

EUR

 

-3,42 %

1.555 følger denne virksomhed

BRETEC

First North Finland

Medical Equipment & Services

Health Care

Overview
Finansielt overblik og estimater
Investor consensus
Sammenligne
-3,42%
-17,43%
-18,48%
-20,18%
-14,86%
-26,32%
-6,55%
-
-34,85%

Bioretec is a medical technology company. The company specializes in the development of medical devices. The product portfolio includes, for example, implants for pediatric and adult orthopedics and other material for bone and soft tissue injuries. In addition to the main business, service and associated ancillary services are also offered. Bioretec operates worldwide with the largest presence in the Nordic region.

Læs mere
Markedsværdi
56,49 mio. EUR
Aktieomsætning
27,63 t EUR
P/E (adj.) (25e)
-11,45
EV/EBIT (adj.) (25e)
-11,01
P/B (25e)
4,18
EV/S (25e)
6,92
Udbytteafkast, % (25e)
-
Coverage
Anbefaling
Akkumulér
Kursmål
2.40 EUR
Opdateret
30.05.2025
Disclaimer
Antti Siltanen
Antti Siltanen

Analytiker

Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
14.8
2025

Delårsrapport Q2'25

13.11
2025

Selskabsgennemgang Q3'25

Risiko
Business risk
Valuation risk
Lav
Høj
Alle
Analyse
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse28.5.2025, 11.00

Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of approximately EUR 9.2 million and publishes the terms and conditions of the fully guaranteed rights issue

Bioretec
Selskabsmeddelelse20.5.2025, 11.00

New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register

Bioretec
Selskabsmeddelelse15.5.2025, 07.15

Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec

Bioretec

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse15.5.2025, 05.00

Bioretec Ltd's business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products

Bioretec
Selskabsmeddelelse8.5.2025, 15.45

Inside information: Bioretec's CEO Alan Donze to resign

Bioretec
Selskabsmeddelelse9.4.2025, 14.15

Bioretec Ltd - Managers' transactions - Alan Donze

Bioretec
Selskabsmeddelelse9.4.2025, 14.00

Bioretec Ltd - Managers' transactions - Michael Piccirillo

Bioretec
Selskabsmeddelelse9.4.2025, 14.00

Bioretec Ltd - Managers' transactions - Kustaa Poutiainen

Bioretec
Selskabsmeddelelse9.4.2025, 14.00

Bioretec Ltd - Managers' transactions - Päivi Malinen

Bioretec
Selskabsmeddelelse9.4.2025, 14.00

Bioretec Ltd - Managers' transactions - Sarah van Hellenberg Hubar-Fisher

Bioretec
Selskabsmeddelelse9.4.2025, 14.00

Bioretec Ltd - Managers' transactions - Justin Barad

Bioretec
Selskabsmeddelelse9.4.2025, 14.00

Bioretec Ltd - Managers' transactions - Antti Vasara

Bioretec
Selskabsmeddelelse21.3.2025, 13.00

Bioretec Ltd's Board of Directors has decided on a new option program for the CEO

Bioretec
Selskabsmeddelelse21.3.2025, 12.30

Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors

Bioretec
Selskabsmeddelelse14.3.2025, 17.30

Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH)

Bioretec
Pressemeddelelse14.3.2025, 17.00

Bioretec Ltd's Annual Report 2024 published

Bioretec
Selskabsmeddelelse14.3.2025, 07.00

New shares in Bioretec Ltd subscribed with option rights have been registered into the Trade Register

Bioretec
Pressemeddelelse7.3.2025, 07.00

Mirva Ekman appointed to Bioretec's Management Team as Quality Director

Bioretec
Selskabsmeddelelse28.2.2025, 10.30

Bioretec: NOTICE OF ANNUAL GENERAL MEETING OF BIORETEC LTD

Bioretec
Pressemeddelelse14.2.2025, 16.30

CE Mark Approval for RemeOs™ Trauma Screw Product Group, featuring four product lines with over 200 individual products, drives global expansion for Bioretec

Bioretec
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team